EB-2 NIW Case Study: Doctor from Uruguay Approved to Improve Healthcare Access through Telemedicine

USCIS issued an RFE questioning whether the proposed endeavor met the national importance standard and whether it justified a waiver of the job offer requirement.

In its initial review, USCIS focused primarily on our client’s individual role, raising concerns about how one professional could generate impact at a national level.

The petition needed to clarify a critical point: his initiative was not limited to a single position, but centered on developing scalable, AI-driven telemedicine solutions designed to improve healthcare access across underserved communities.

The response needed to show how these technologies could deliver system-wide benefits, strengthen healthcare delivery, and produce measurable impact beyond individual patient care.

Attorney Kwon approached the RFE with a focused strategy. Rather than relying on entirely new documentation, the response clarified what had already been submitted, and ensured its value was impossible to overlook.

The legal team explained the existing evidence to better highlight the true scope and impact of the client’s initiative. This shift in focus, from the individual to the broader initiative, made it clear that the case was always about a scalable solution with national impact.

The response also included more detail about one of the client’s ongoing projects to show a real-world example of how the initiative was already taking shape, supporting both its feasibility and application.

The RFE record also included financial documentation to demonstrate the client’s commitment and ability to move the project forward. This added another layer of credibility to the petition.

As Attorney Kwon explained, “Our goal was not to start over, but to make the case clearer, ensuring the officer could fully understand the value of what had already been submitted and see its impact in the right context.”

USCIS approved the EB-2 NIW petition following review of the RFE response. The decision recognized the national importance of the client’s initiative and his ability to advance a scalable, technology-driven solution to improve healthcare access.

The response successfully clarified how AI-powered telemedicine tools and data-driven systems address critical gaps in care, particularly in underserved and resource-limited communities.

With the I-140 approval secured, our client is now positioned to further develop and implement his AI-driven telemedicine initiative in the United States.

These solutions are designed to help providers respond faster and reach patients in areas with limited healthcare access.